UK News NICE has approved Pemigatinib (Pemaryze) as first treatment for people w
- This topic has 1 reply, 1 voice, and was last updated 2 years, 8 months ago by
.
Viewing 2 posts - 1 through 2 (of 2 total)
-
Posts
-
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30109-1/fulltext
Thanks to Elsevier Ltd for this piece.
Patients with rare bile duct cancer set to benefit from life extending treatment
Thanks,
Gavin
Hi all,
This news came out today in the UK so please all UK patients, loved ones etc please have a read –
NICE has approved Pemigatinib (Pemaryze) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma).
http://www.pharmafile.com/news/583430/nice-approves-treatment-rare-bile-duct-cancer
Great news.
Thanks all,
Gavin
Viewing 2 posts - 1 through 2 (of 2 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.